NOWDiagnostics

About NOWDiagnostics

NOWDiagnostics develops rapid diagnostic tests that require only a single drop of blood or saliva, providing results in as little as 10 to 15 minutes. Their technology enables at-home testing for conditions like COVID-19 and syphilis, facilitating immediate health assessments without the need for laboratory visits.

```xml <problem> Traditional laboratory-based diagnostic testing often requires specialized equipment and trained personnel, leading to delays in obtaining results and limiting accessibility, particularly in point-of-care or at-home settings. This can hinder timely diagnosis and treatment for various health conditions. </problem> <solution> NOWDiagnostics develops and manufactures rapid diagnostic tests that utilize a single drop of blood or saliva to provide results in 10-15 minutes. These tests are designed for point-of-care or over-the-counter use, enabling immediate health assessments without the need for laboratory visits. The tests can be visually interpreted or digitally read using a dedicated analyzer, providing flexibility in result interpretation. The company's technology aims to decentralize diagnostic testing, making it more accessible and convenient for both healthcare professionals and individuals. </solution> <features> - Rapid results in 10-15 minutes using a single drop of blood or saliva - Fingerstick and saliva-based test formats available - Tests can be visually interpreted or digitally read using a dedicated analyzer - Tests available for conditions such as COVID-19 and syphilis - Intended for point-of-care or over-the-counter use - Collection devices available for sample preparation </features> <target_audience> The primary target audience includes healthcare professionals such as pharmacists and clinicians, as well as individuals seeking convenient at-home testing options. </target_audience> ```

What does NOWDiagnostics do?

NOWDiagnostics develops rapid diagnostic tests that require only a single drop of blood or saliva, providing results in as little as 10 to 15 minutes. Their technology enables at-home testing for conditions like COVID-19 and syphilis, facilitating immediate health assessments without the need for laboratory visits.

0

Find Investable Startups and Competitors

Search thousands of startups using natural language

NOWDiagnostics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

NOWDiagnostics develops rapid diagnostic tests that require only a single drop of blood or saliva, providing results in as little as 10 to 15 minutes. Their technology enables at-home testing for conditions like COVID-19 and syphilis, facilitating immediate health assessments without the need for laboratory visits.

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Traditional laboratory-based diagnostic testing often requires specialized equipment and trained personnel, leading to delays in obtaining results and limiting accessibility, particularly in point-of-care or at-home settings. This can hinder timely diagnosis and treatment for various health conditions.

Solution

NOWDiagnostics develops and manufactures rapid diagnostic tests that utilize a single drop of blood or saliva to provide results in 10-15 minutes. These tests are designed for point-of-care or over-the-counter use, enabling immediate health assessments without the need for laboratory visits. The tests can be visually interpreted or digitally read using a dedicated analyzer, providing flexibility in result interpretation. The company's technology aims to decentralize diagnostic testing, making it more accessible and convenient for both healthcare professionals and individuals.

Features

Rapid results in 10-15 minutes using a single drop of blood or saliva

Fingerstick and saliva-based test formats available

Tests can be visually interpreted or digitally read using a dedicated analyzer

Tests available for conditions such as COVID-19 and syphilis

Intended for point-of-care or over-the-counter use

Collection devices available for sample preparation

Target Audience

The primary target audience includes healthcare professionals such as pharmacists and clinicians, as well as individuals seeking convenient at-home testing options.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.